Maryland State Retirement & Pension System’s 10x Genomics TXG Stock Holding History

Maryland State Retirement & Pension System’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,277	Closed	-$215K	–	1575
2024 Q1	$215K	Hold	7,277	–	–	﹤0.01%	1477
2023 Q4	$407K	Hold	7,277	–	–	0.01%	1247
2023 Q3	$300K	Hold	7,277	–	–	0.01%	1354
2023 Q2	$406K	Hold	7,277	–	–	0.01%	1219
2023 Q1	$406K	Buy	7,277 +997	+16%	+$46.6K	0.01%	1166
2022 Q4	$229K	Buy	+6,280	New	+$205K	0.01%	1400
2022 Q3	–	Sell	-6,280	Closed	-$284K	–	1286
2022 Q2	$284K	Hold	6,280	–	–	0.01%	1300
2022 Q1	$478K	Hold	6,280	–	–	0.01%	1091
2021 Q4	$935K	Hold	6,280	–	–	0.02%	686
2021 Q3	$922K	Hold	6,280	–	–	0.03%	666
2021 Q2	$1.21M	Buy	6,280 +1,890	+43%	+$342K	0.04%	438
2021 Q1	$795K	Buy	+4,390	New	+$758K	0.03%	558

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Maryland State Retirement & Pension System's TXG Position: Q2 2024 in Review

Maryland State Retirement & Pension System sold out of 10x Genomics (TXG) in Q2 2024, closing a stake of 7,277 shares — an estimated $215K sold.

Maryland State Retirement & Pension System first reported a position in TXG in Q1 2021 and held it in 12 quarters. The position peaked at $1.21M in Q2 2021. 261 funds tracked by Wall St. Rank hold TXG as of Q2 2024.

Maryland State Retirement & Pension System reported no remaining 10x Genomics position as of Q2 2024 after selling out during the quarter.
Maryland State Retirement & Pension System sold 7,277 10x Genomics shares in Q2 2024, an estimated $215K.
Maryland State Retirement & Pension System first reported a position in 10x Genomics in Q1 2021 and held it in 12 quarters.
Maryland State Retirement & Pension System's 10x Genomics position peaked at $1.21M in Q2 2021.
261 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2024.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2024, filed 30 Jul 2024.